Glenmark Pharma receives USFDA approval for Sirolimus Tablets

Glenmarks current portfolio consists of 165 products authorized for distribution in the U.S. marketplace and 45 ANDAs pending approval with the U.S. FDA.

from India Infoline News Service https://ift.tt/31mUQVj